2016 - Dynacure

Home
Our Focus
Our Pipeline
Our Vision
Our Leadership
Patients & Families
Investors
News & Events
Careers & Cultures
Publications

Kurma Partners and Idinvest Partners launches Dynacure a new company specialized in rare neuromuscular diseases

siteadmin2020-11-07T03:02:51-08:00October 24, 2016|

Community

Location

Bioparc III
850, Boulevard Sébastien Brant
F-67400 Illkirch-Graffenstaden
France

1657 The Fairway, #176
Jenkintown, PA 19046
USA

Email

info@dynacure.com

Facebook Twitter LinkedIn

Page load link

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits, and to help us analyzing the audience of the website. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings REJECT ACCEPT

Manage consent

Cookies Privacy Overview

This website uses cookies while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. You have the option to opt-out from these cookies (see also page “Cookies”). We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Cookies that may not be particularly necessary for the website to function and are used specifically by Dynacure, as data controller, to collect user personal data via analytics are termed as non-necessary cookies. It is mandatory to procure your user consent prior to running these cookies on our website. After consenting, you may withdraw your consent at any time via the cookies page. Refusing these cookies will have no impact on your individual use of the website but will impact our ability to improve it for the benefit of future users.

SAVE & ACCEPT

Go to Top